Paper Details

  1. Home
  2. Paper Details

Comparison of transesophageal echocardiography findings after different anticoagulation strategies in patients with atrial fibrillation: a systematic review and meta-analysis.

Author: ChenSong-Zan, HuShen-Jiang, WangXi-Ying, YangJian, ZhangChi, ZhangXuan

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

This meta-analysis compares the incidence of left atrial thrombi (LAT) between different anticoagulants. The results indicate that both vitamin K antagonists (VKAs) and non-vitamin K antagonist oral anticoagulants (NOACs) have been used to treat patients with atrial fibrillation and those undergoing ablation.
Paper Details　
Original Abstract of the Article :
High risk of embolic events exists in both patients with chronic atrial fibrillation (AF) and patients in the perioperative period of ablation (effective treatment for AF). Therefore, anticoagulant therapy is important. Oral anticoagulants can be divided into two major categories: vitamin K antagoni...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878716/

データ提供：米国国立医学図書館（NLM）

Anticoagulation Strategies for Atrial Fibrillation: A Comparative Analysis

This research delves into the crucial area of [anticoagulation] for patients with [atrial fibrillation (AF)], a condition that increases the risk of [embolic events]. The authors compare the effectiveness of two major categories of [oral anticoagulants]: [vitamin K antagonists (VKAs)] and [non-vitamin K antagonist oral anticoagulants (NOACs)]. The study analyzes the incidence of [left atrial thrombi (LAT)] in patients receiving different [anticoagulation] regimens, providing valuable insights for [clinicians] in selecting the most appropriate treatment for their patients.

Navigating the Desert of Anticoagulation Options

The study provides a comprehensive overview of the [anticoagulation] options available for [AF] patients, navigating the diverse landscape of [VKAs] and [NOACs]. Imagine a desert with numerous paths leading to different destinations - this study helps [clinicians] to make informed decisions about the best [anticoagulation] route for their patients. The authors offer valuable insights into the potential benefits and risks associated with each approach.

A New Era of Anticoagulation for Atrial Fibrillation

This research highlights the ongoing evolution of [anticoagulation] strategies for [AF] patients, emphasizing the emergence of [NOACs] as a viable alternative to [VKAs]. The study underscores the importance of [evidence-based research] in guiding [clinical practice] and ensuring that patients receive the most effective and safe treatment for their condition. This research is a testament to the ongoing quest for [innovation] in [cardiovascular medicine], seeking to find new ways to improve patient outcomes and enhance their quality of life.

Dr.Camel's Conclusion

This study is a valuable resource for [clinicians] navigating the complex world of [anticoagulation] for [AF] patients. The authors provide a comprehensive analysis of the available [treatment options], highlighting the strengths and limitations of [VKAs] and [NOACs]. This research underscores the importance of [evidence-based decision-making] in [anticoagulation] management, ensuring that patients receive the most appropriate and effective care for their individual needs.

Date :
  1. Date Completed 2020-05-26
  2. Date Revised 2020-05-26
Further Info :

Pubmed ID

31771529

DOI: Digital Object Identifier

PMC6878716

Related Literature

Article Analysis
・Side Effects of rivaroxaban
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.